References
- YuPeng L, YuXue Z, PengFei L, et al. Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies. Cancer Epidemiol Biomarkers Prev. 2015;24:1086–1093.
- Allott EH, Howard LE, Cooperberg MR, et al. Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2014;23:2349–2356.
- Jung J, Lee C, Lee C, et al. Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer. Korean J Urol. 2015;56:630–636.
- Mikkelsen MK, Thomsen FB, Berg KD, et al. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy. Scand J Urol. 2017;51:464–469.
- Mucci LA, Stampfer MJ. Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer. J Clin Oncol. 2014;32:1–2.
- Murtola TJ, Peltomaa AI, Talala K, et al. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer. European Urology Focus. 2017;3:212–220.
- Keskivali T, Kujala P, Visakorpi T, et al. Statin use and risk of disease recurrence and death after radical prostatectomy. Prostate. 2016;76:469–478.
- Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol. 1994;33:365–369.
- Fimlab homepage. [http://www.fimlab.fi/sivu.tmpl?sivu_id=222] Accessed at 28 Feb. 2017.
- Martikainen J, Rajaniemi S. Drug reimbursement systems in EU Member states, Iceland and Norway. Available at: [https://helda.helsinki.fi/bitstream/handle/10138/13932/Drug_reimbursement.pdf?sequence=1] Accessed at 28th. Feb. 2017.
- Gutt R, Tonlaar N, Kunnavakkam R, et al. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol. 2010;28:2653–2659.
- Kang M, Jeong CW, Ku JH, et al. Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy. PLoS One. 2015;10:e0122438.
- Wettstein MS, Saba K, Umbehr MH, et al. Prognostic role of preoperative serum lipid levels in patients undergoing radical prostatectomy for clinically localized prostate cancer. Prostate. 2017;77:549–556.
- Raval AD, Thakker D, Negi H, et al. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2016;19:222–162.
- Scosyrev E, Tobis S, Donsky H, et al. Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies. BJU Int. 2013;111:E71–E77.